MARC보기
LDR00000nmm u2200205 4500
001000000330119
00520241024151610
008181129s2017 ||| | | | eng d
020 ▼a 9780355555387
035 ▼a (MiAaPQ)AAI10742639
035 ▼a (MiAaPQ)wustl:12408
040 ▼a MiAaPQ ▼c MiAaPQ ▼d 248032
0491 ▼f DP
0820 ▼a 616
1001 ▼a Sutphen, Courtney.
24510 ▼a Longitudinal Cerebrospinal Fluid Biomarkers of Alzheimer Disease: Movement Toward the Diagnosis, Prognosis and Staging of Disease.
260 ▼a [S.l.] : ▼b Washington University in St. Louis., ▼c 2017
260 1 ▼a Ann Arbor : ▼b ProQuest Dissertations & Theses, ▼c 2017
300 ▼a 194 p.
500 ▼a Source: Dissertation Abstracts International, Volume: 79-05(E), Section: B.
500 ▼a Advisers: Anne M. Fagan
5021 ▼a Thesis (Ph.D.)--Washington University in St. Louis, 2017.
506 ▼a This item is not available from ProQuest Dissertations & Theses.
520 ▼a Alzheimer's disease (AD) is a devastating neurodegenerative disease that slowly claims the memories and experiences that comprise the life experiences of individuals that suffer from the disease. Despite a continually accelerating pace of resear
520 ▼a One important aspect of AD treatment is identification. It is now recognized that the disease begins more than a decade before the signature symptoms of cognitive impairment become apparent. Identifying individuals in this "preclinical" disease
520 ▼a Biomarkers, indicators of normal biological or pathological processes that may be studied as a means to give individuals a disease diagnosis, prognosis, or theragnosis -- provided a treatment is available for the disease in question -- are of pa
520 ▼a The current work begins with an overview of biomarker modalities used in AD
520 ▼a The ACS cohort is comprised of middle-aged, cognitively normal individuals recruited on a volunteer basis from community dwelling participants with and without a family history of AD. The ADNI cohort is comprised of older individuals also recrui
520 ▼a In both cohorts, it was found that CSF markers of amyloid plaques -- one of two required pathological hallmarks that indicate AD -- changed earlier than those of tau tangles, the second required pathological hallmark.
520 ▼a Currently, examining biomarkers on a group-wide basis is the best way to get an accurate picture of biomarkers at baseline and followup lumbar punctures (LPs). As the goal is to be able to give individual people a diagnosis and prognosis of thei
590 ▼a School code: 0252.
650 4 ▼a Neurosciences.
690 ▼a 0317
71020 ▼a Washington University in St. Louis. ▼b Biology & Biomedical Sciences (Neurosciences).
7730 ▼t Dissertation Abstracts International ▼g 79-05B(E).
773 ▼t Dissertation Abstract International
790 ▼a 0252
791 ▼a Ph.D.
792 ▼a 2017
793 ▼a English
85640 ▼u http://www.riss.kr/pdu/ddodLink.do?id=T14996798 ▼n KERIS
980 ▼a 201812 ▼f 2019
990 ▼a 관리자 ▼b 관리자